PathGen Diagnostik Teknologi disrupts the molecular diagnostics market for cancer through inclusive, robust, and affordable platforms. With a strong ecosystem of academic-business-government-community partnership, PathGen seeks to democratize precision medicine, especially in developing countries, and enable molecular diagnostics for all.